Chronic Lyme Disease The Standard of Care · Chronic Lyme Disease—The Standard of Care ξTwo...

22
Chronic Lyme DiseaseThe Standard of Care ξ Two equally legitimate but divergent standards of care currently exist for the diagnosis and treatment of Lyme disease: IDSA guidelines and ILADS guidelines 1) Johnson L, Stricker RB. Treatment of Lyme disease: a medicolegal assessment. Expert Rev Anti Infect Ther. 2004 Aug;2(4):533-57. 2) Evidence-based guidelines for the management of Lyme Disease. Cameron, Horowitz, et al. Expert Review of Anti Infective Therapy 2(1) 2004 ξ Many doctors in the United States do not follow IDSA guidelines. They treat for seronegative disease, and treat for extended periods of time. “For chronic Lyme disease, 57% of responders treat 3 months or more.” ξ Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 1996 Mar-Apr;24(2):182- 6.

Transcript of Chronic Lyme Disease The Standard of Care · Chronic Lyme Disease—The Standard of Care ξTwo...

Chronic Lyme Disease—The Standard of Care

ξ Two equally legitimate but divergent standards of care currently exist for the diagnosis and treatment of Lyme disease: IDSA guidelines and ILADS guidelines

1) Johnson L, Stricker RB. Treatment of Lyme disease: a medicolegal assessment. Expert Rev Anti Infect Ther. 2004 Aug;2(4):533-57.

2) Evidence-based guidelines for the management of Lyme Disease.

Cameron, Horowitz, et al. Expert Review of Anti Infective Therapy 2(1) 2004

ξ Many doctors in the United States do not follow IDSA guidelines. They treat for seronegative disease, and treat for extended periods of time. “For chronic Lyme disease, 57% of responders treat 3 months or more.”

ξ Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 1996 Mar-Apr;24(2):182-6.

CDC Data 2013: Over 50% of Physicians do not treat Lyme Disease using IDSA guidelines, & Treat for

Longer Periods

CDC Survey 2013: No Need to Use 2 Tiered Testing for Lyme Disease

Need to Change the CDC/EUCALB criteria

• The IDSA and the European Concerted Action on Lyme Borreliosis (EUCALB, Diagnosis: www.eucalb.com; September 2013) recommend a two-tier testing approach. According to these guidelines, an immunoblot is not to be performed if the ELISA is negative, despite the poor sensitivity of ELISA tests ranging from 34 to 70.5%.

• Effect: Missing roughly half of the people with Lyme disease

-Marangoni, A. et al. Comparative evaluation of three different ELISA methods for the

diagnosis of early culture-confirmed Lyme disease in Italy. J. Med. Microbiol. 54, 361-367 (2005);

-Ang, C.W.,et al. T. Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur. J. Clin. Microbiol. Infect. Dis. 30, 1027-1032 (2011).

-Wojciechowska-Koszko, et al. Serodiagnosis of borreliosis: indirect immunofluorescence assay, enzymelinked immunosorbent assay and immunoblotting. Arch. Immunol. Ther. Exp. 59, 69-77 (2011).

Lyme Disease Diagnosis: Problems with Testing

1)Intra and Interlaboratory Variation in LD testing -Marangoni J Med Microbiol 2005: 3 different commercial

Elisa tests showed discrepant results. Sensitivity for the same sera 36,8% to 70.5%

-De Marteno Med Mal Infect 2007: Compared 14 Elisa test kits for the diagnosis of neuro Lyme. Sensitivity varied from 20.9% -97.7%

2) Testing Issues: Different species of Borrelia: Rudenko FEMS Microbiol Letter 2009 ; Bouattour Arch Inst Pasteur Tunis 2004 ; Lopes de Carvalho Clin Rheumatol 2008

3) Problems with 2 -Tiered Testing -In 2005, John’s Hopkins University study: found CDC two

tiered testing missed up to 55% of positive Lyme cases Coulter,et al.,J Clin Microbiol 2005;43:5080-5084. CDC correspondance with NYS DOH

Understanding the Role of Laboratory Testing in Lyme Disease and Other Tick Borne Diseases

– The utility of the Western Blot is based on understanding specific bands which reflect exposure to Bb: 23, 31, 34, 39, 83-93

– PCR testing is an important diagnostic tool for seronegative patients, but many require multiple sets over time,? Culture (Advanced Labs)/ ? LTT

– 10-20% of the Borrelia presently in ticks (US) are not Borrelia burgdorferi, but are genetically related to Borrelia miyamotoi, the agent of relapsing fever in Japan. These organisms will not test positive by ELISA, Western Blot, or PCR assays for Lyme Disease. Other tick-borne diseases such as Babesia and Bartonella also may not test positive

Sont vos symptômes dus à la

maladie de Lyme?

Prendre le questionnaire

symptomatologique des SIMS (Syndrome Infectieux Multi Systémique)

/ML de Horowitz dans mon livre

C’est un outil indispensable pour

déterminer la probabilité d’un SIMS et/ou

d’une maladie de Lyme (sans rash EM)

Rubrique , Questionnaire SIMS

Les symptômes le plus souvent reliés à

la maladie de Lyme/SIMS:

Fatigue, lassitude

Maux de tête, avec raideur de la nuque ou du dos

Douleurs articulaires et musculaires (qui migrent)

Fourmillements, engourdissements et/ou sensation de

brûlure aux extrémités (qui peuvent aussi migrer)

Confusion, difficulté à penser, difficulté à se concentrer

ou à lire, mauvaise mémoire à court terme

Difficultés à parler ou à écrire

Troubles du sommeil – Dort trop ou trop peu, réveils

précoces

Fièvres, sueurs, frissons inexpliqués (? Babesiose)

L'approche SIMS/ML appliquée aux maladies chroniques : La grille d'évaluation en 16 pts

1.Infections: bactériennes, parasitaires, virales et fongiques

2. Dysfonctionnement immunitaire

3.Inflammation 4. Intoxications : hypersensibilité chimique multiple, maladies environnementales

5. Allergies : alimentaires, médicamenteuses (↑ cytokines)

6. Carences nutritionnelles et enzymatiques

7. Dysfonctionnement mitochondrial

8. Troubles psychologiques

9. Dysfonctionnements neurologiques 10.Troubles endocriniens 11. Troubles du sommeil (↑ IL-6)

12. Dysfonctionnement du SNA 13.Troubles gastro-intestinaux

14. Élévation des enzymes hépatiques 15. Syndromes douloureux (neuropathies…)16. Perte de forme physique

Tick-Borne Co-Infections in SIMS • Borrelia (multiple species, including relapsing fever B.

hermsii, B. miyamotoi, ? STARI)

• Bacteria of the genera Neorickettsia, Ehrlichia, Anaplasma

• Parasites: Babesia (microti, WA-1/duncani, divergens), others: FL1953 (protomyxoa rheumatica), filariasis, toxoplasmosis, intestinal parasites

• Bartonella (multiple species)

• Mycoplasma (multiple species)

• Rickettsial inf’s: RMSF, Typhus, Q-fever

• Tularemia, Brucella

• Viruses: Heartland virus, DTV/Powassan virus, TBEV..

Designing Combination Therapies ML/SIMS

Cell Wall:

Penicillins:

Amoxicillin

Bicillin

Cephalosporins

Ceftin

Cedax

Omnicef

Suprax

IV Rocephin

IV Claforan

Other

IV Vancomycin

IV Primaxin

Cystic Forms:

Flagyl

Tinidazole

GSE

Plaquenil

Intracellular:

Tetracyclines

doxy, Mino

Macrolides

Zithromax,

Biaxin

QuinolonesCipro,

Levaquin,

Avelox,

Factive

Rifampin

Treatment for Borrelia burgdorferi/plus Treatment for Biofilms

Combination Antibiotic Regimens for Bartonella/Mycoplasma/IC bacteria

• Plaquenil/ doxycycline/rifampin/nystatin/?Septra • Plaquenil/doxycycline/Zithromax/nystatin • Plaquenil/doxycycline/Levaquin/nystatin • Plaquenil /Zithromax/Septra • Plaquenil/Zithromax/rifampin • Plaquenil/rifampin/Factive • Plaquenil/rifampin/Factive/tetracyclines (Doxy) -Malarone (and Mepron) may be added to the above regimens with antimalarial herbs if there is associated babesiosis, but it’s use in regimens where rifampin is used may lead to lower drug levels of atovaquone (the same is true for tetracyclines, but the drugs may still be efficacious if dosed at higher levels) -

Herbal/Integrative Therapies used for Lyme Disease & Co-Infections

• Buhner protocol (Samento, Andrographis, J K..)

• Schart protocol (Diflucan/ Pen)

• Zhang protocol (TCM→Coptis, HH, Allicin, Circ P..)

• Homeopathic protocols (Ledum, syphilitic and malarial nosodes)

• Salt & Vit C protocol

• Rife machines, Coil machines

• Byron White protocol (A-L, A-Bab, A-Bart)

• Cowden protocol (Samento, Banderol, Cumunda..)

• Beyond Balance (MC Bab 2, Bab 1, BB-1..)

-How does one choose? Are their studies on their efficacy in the clinical setting?

SIMS: Un modèle multifactoriel pour

toutes les maladies chroniques

Ces 16 causes multifactorielles sont souvent au

cœur des états pathologiques chroniques.

Determiner en chaque personne des facteurs

multiples qui sont responsable pour leurs

symptômes

Une fois que tous les différents facteurs sont

découvert et convenablement traités, la plupart

des gens avec du fatigue, les douleurs, troubles

de sommeil, confusion, difficultés à penser, ou

mauvaise mémoire à court terme aller mieux

Co-infections en France: Babesia

Duncani/WA-1

Co-infections en France

Intoxications: Augmentation les metaux

lourdes en France

Intoxications: Mycotoxin testing positive

in France

Vous Pouvez Avoir L’Espoir!

Chez les patients français qui sont venus

me voir, lorsqu'on a utilisé la grille de

diagnostic différentiel en 16 points, on a

trouvé que de multiples causes à leurs

symptômes chroniques (résistants) se

superposaient. Une fois traités, l'état de

ces patients qui souffraient depuis des

années a été amélioré.

Douleurs, fatigue, confusion…

Pourquoi je ne m’en sors pas ?

Résoudre le mystère de Lyme et des maladies

chroniques inexpliquées: Editions Thierry Soucar

Juin 2014

J Ju

Why Can't I Get Better?

Richard Horowitz, M.D.

HC ISBN-13: 978-1-250-01940-0

ISBN-10: 1-250-01940-0

6 1/8 9 ¼ ● 526 pages

EISBN-13: 978-1-250-03848-7, St Martin’s Press et Editions Thierry Soucar 2014